Pure Global
NCT06322927

PatIent exPeRiences and prEFerence of trEatment foR Multiple Myeloma

The Christie NHS Foundation Trust·ClinicalTrials.gov·otherNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Multiple Myeloma
Drug/Device/Intervention
Patient Interview
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
The Christie NHS Foundation Trust
Location
Manchester, United Kingdom
Timeline & enrollment
Phase
N/A
Start date
Mar 31, 2024
End date
Sep 30, 2024
Enrollment
15 participants
Primary outcome

Patient Experience and Preference

Summary

This is a qualitative (interview) study to explore the experiences of people receiving
 treatment for MM and to understand what matters most to them when making treatment decisions.

ICD-10 classifications
Multiple myelomaMultiple myeloma and malignant plasma cell neoplasmsOther myeloid leukaemiaMyeloid leukaemiaOther myelodysplastic syndromes
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06322927
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06322927 through Pure Global AI's free database. This phase not specified trial is sponsored by The Christie NHS Foundation Trust and is currently Not yet recruiting. The study focuses on Multiple Myeloma. Target enrollment is 15 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.